These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 28228428)

  • 1. Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control]).
    Parkash R; Wells GA; Sapp JL; Healey JS; Tardif JC; Greiss I; Rivard L; Roux JF; Gula L; Nault I; Novak P; Birnie D; Ha A; Wilton SB; Mangat I; Gray C; Gardner M; Tang ASL
    Circulation; 2017 May; 135(19):1788-1798. PubMed ID: 28228428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective complex fractionated atrial electrograms targeting for atrial fibrillation study (SELECT AF): a multicenter, randomized trial.
    Verma A; Sanders P; Champagne J; Macle L; Nair GM; Calkins H; Wilber DJ
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):55-62. PubMed ID: 24425420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of brain natriuretic peptide in atrial fibrillation: a substudy of the Substrate Modification with Aggressive Blood Pressure Control for Atrial Fibrillation (SMAC-AF) trial.
    Weng W; Choudhury R; Sapp J; Tang A; Healey JS; Nault I; Rivard L; Greiss I; Bernick J; Parkash R
    BMC Cardiovasc Disord; 2021 Sep; 21(1):445. PubMed ID: 34530738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension: The ERADICATE-AF Randomized Clinical Trial.
    Steinberg JS; Shabanov V; Ponomarev D; Losik D; Ivanickiy E; Kropotkin E; Polyakov K; Ptaszynski P; Keweloh B; Yao CJ; Pokushalov EA; Romanov AB
    JAMA; 2020 Jan; 323(3):248-255. PubMed ID: 31961420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.
    Di Biase L; Mohanty P; Mohanty S; Santangeli P; Trivedi C; Lakkireddy D; Reddy M; Jais P; Themistoclakis S; Dello Russo A; Casella M; Pelargonio G; Narducci ML; Schweikert R; Neuzil P; Sanchez J; Horton R; Beheiry S; Hongo R; Hao S; Rossillo A; Forleo G; Tondo C; Burkhardt JD; Haissaguerre M; Natale A
    Circulation; 2016 Apr; 133(17):1637-44. PubMed ID: 27029350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.
    Morillo CA; Verma A; Connolly SJ; Kuck KH; Nair GM; Champagne J; Sterns LD; Beresh H; Healey JS; Natale A;
    JAMA; 2014 Feb; 311(7):692-700. PubMed ID: 24549549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Complete Versus Incomplete Circumferential Lines Around the Pulmonary Veins During Catheter Ablation of Paroxysmal Atrial Fibrillation: Results From the Gap-Atrial Fibrillation-German Atrial Fibrillation Competence Network 1 Trial.
    Kuck KH; Hoffmann BA; Ernst S; Wegscheider K; Treszl A; Metzner A; Eckardt L; Lewalter T; Breithardt G; Willems S;
    Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e003337. PubMed ID: 26763226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve-year follow-up of catheter ablation for atrial fibrillation: A prospective, multicenter, randomized study.
    Bertaglia E; Senatore G; De Michieli L; De Simone A; Amellone C; Ferretto S; La Rocca V; Giuggia M; Corrado D; Zoppo F; Stabile G
    Heart Rhythm; 2017 Apr; 14(4):486-492. PubMed ID: 27989681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stand-Alone Pulmonary Vein Isolation Versus Pulmonary Vein Isolation With Additional Substrate Modification as Index Ablation Procedures in Patients With Persistent and Long-Standing Persistent Atrial Fibrillation: The Randomized Alster-Lost-AF Trial (Ablation at St. Georg Hospital for Long-Standing Persistent Atrial Fibrillation).
    Fink T; Schlüter M; Heeger CH; Lemes C; Maurer T; Reissmann B; Riedl J; Rottner L; Santoro F; Schmidt B; Wohlmuth P; Mathew S; Sohns C; Ouyang F; Metzner A; Kuck KH
    Circ Arrhythm Electrophysiol; 2017 Jul; 10(7):. PubMed ID: 28687670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial).
    Darkner S; Chen X; Hansen J; Pehrson S; Johannessen A; Nielsen JB; Svendsen JH
    Eur Heart J; 2014 Dec; 35(47):3356-64. PubMed ID: 25182250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Atrial Fibrillation Episode Duration With Arrhythmia Recurrence Following Ablation: A Secondary Analysis of a Randomized Clinical Trial.
    Andrade JG; Deyell MW; Verma A; Macle L; Champagne J; Leong-Sit P; Novak P; Badra-Verdu M; Sapp J; Khairy P; Nattel S
    JAMA Netw Open; 2020 Jul; 3(7):e208748. PubMed ID: 32614422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results from a single-blind, randomized study comparing the impact of different ablation approaches on long-term procedure outcome in coexistent atrial fibrillation and flutter (APPROVAL).
    Mohanty S; Mohanty P; Di Biase L; Bai R; Santangeli P; Casella M; Dello Russo A; Tondo C; Themistoclakis S; Raviele A; Rossillo A; Corrado A; Pelargonio G; Forleo G; Natale A
    Circulation; 2013 May; 127(18):1853-60. PubMed ID: 23572499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No Benefit of Complex Fractionated Atrial Electrogram Ablation in Addition to Circumferential Pulmonary Vein Ablation and Linear Ablation: Benefit of Complex Ablation Study.
    Wong KC; Paisey JR; Sopher M; Balasubramaniam R; Jones M; Qureshi N; Hayes CR; Ginks MR; Rajappan K; Bashir Y; Betts TR
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1316-24. PubMed ID: 26283145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [FUNCTIONAL PARAMETERS OF BLOOD CIRCULATION IN FIRST THREE MONTHS AFTER RADIOFREQUENCY ABLATION OF ATRIAL FIBRILLATION AND FLUTTER].
    Brynza M; Bilchenko A; Makharynska E; Shevchuk M; Yabluchanskyi N
    Georgian Med News; 2018 Jun; (279):73-79. PubMed ID: 30035725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Study of Persistent Atrial Fibrillation Ablation: Ablate in Sinus Rhythm Versus Ablate Complex-Fractionated Atrial Electrograms in Atrial Fibrillation.
    Bassiouny M; Saliba W; Hussein A; Rickard J; Diab M; Aman W; Dresing T; Callahan T; Bhargava M; Martin DO; Shao M; Baranowski B; Tarakji K; Tchou PJ; Hakim A; Kanj M; Lindsay B; Wazni O
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003596. PubMed ID: 26857909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year follow-up outcome after catheter ablation of persistent atrial fibrillation using a sequential biatrial linear defragmentation approach: What does atrial fibrillation termination during the procedure imply?
    Miyazaki S; Taniguchi H; Kusa S; Nakamura H; Hachiya H; Hirao K; Iesaka Y
    Heart Rhythm; 2017 Jan; 14(1):34-40. PubMed ID: 27590435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcome of Electrophysiologically Guided Ablation for Nonparoxysmal Atrial Fibrillation Using a Novel Real-Time 3-Dimensional Mapping Technique: Results From a Prospective Randomized Trial.
    Pappone C; Ciconte G; Vicedomini G; Mangual JO; Li W; Conti M; Giannelli L; Lipartiti F; McSpadden L; Ryu K; Guazzi M; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2018 Mar; 11(3):e005904. PubMed ID: 29535136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmia Termination Versus Elimination of Dormant Pulmonary Vein Conduction as a Procedural End Point of Catheter Ablation for Paroxysmal Atrial Fibrillation: A Prospective Randomized Trial.
    Theis C; Konrad T; Mollnau H; Sonnenschein S; Kämpfner D; Potstawa M; Ocete BQ; Bock K; Himmrich E; Münzel T; Rostock T
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1080-7. PubMed ID: 26297786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).
    Yamabe H; Kaikita K; Matsumura T; Iwasa A; Koyama J; Uemura T; Morikami Y; Tsunoda R; Morihisa K; Fujimoto K; Kajiwara I; Matsui K; Tsujita K; Ogawa H
    J Cardiol; 2018 Feb; 71(2):129-134. PubMed ID: 28886992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Midregional N-Terminal Pro-Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study.
    Badoz M; Serzian G; Favoulet B; Sellal JM; De Chillou C; Hammache N; Laurent G; Mebazaa A; Ecarnot F; Bardonnet K; Seronde MF; Schiele F; Meneveau N
    J Am Heart Assoc; 2021 Jul; 10(13):e020917. PubMed ID: 34187182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.